Low BDNF is associated with cognitive deficits in patients with type 2 diabetes
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Objective Studies suggest that brain-derived neurotrophic factor (BDNF) plays an essential role in regulating memory-related neuroplasticity in the hippocampus. Type 2 diabetes (T2DM) is associated with impairment in many domains of cognitive function which may result from reduced BDNF; however, the correlation of BDNF with cognitive impairment in T2DM has not been investigated. Materials and methods We compared 208 patients with T2DM to 212 normal controls on serum BDNF and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Results Serum BDNF levels were significantly decreased in T2DM patients compared to normal controls (p 0.05) of RBANS were markedly lower in T2DM than controls. There was a positive relationship between serum BDNF and delayed memory in patients with T2DM. Conclusion Our results suggest that BDNF may play a role in the pathophysiology of cognitive deficits, especially delayed memory in T2DM.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, a significant decline of BDNF was observed in patients with T2DM, and it was associated with cognitive impairment, which was not observed in non-diabetic controls [64].”
From Neuroprotective effect of SGLT2 inhibitors. (2021) · cites this paper as [64]
Citations
Cites
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888 · cited 1×
“Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family of growth factors and is essential in modulating memory-associated neuroplasticity through regulating cell survival, proliferation, and synaptic growth in the developing central nervous system (Poo 2001; Egan et al. 2003).”
BackgroundRandolph, C., Tierney, M. C., Mohr, E., & Chase, T. N. (1998) · Journal of Clinical and Experimental Neuropsychology · doi:10.1076/jcen.20.3.310.823 · Cited by 2,519 · cited 1×
“We individually administered the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS, Form A) (Randolph et al. 1998) to measure cognitive functioning of all subjects.”
MethodRisk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187 · cited 3×
“disease and vascular dementia, compared with those without T2DM (Biessels et al. 2006).”
BackgroundResultInfluentialDiabetic nephropathy: diagnosis, prevention, and treatment
Gross, J. L., de Azevedo, M. J., Silveiro, S. P., Canani, L. H., Caramori, M. L., & Zelmanovitz, T. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.164 · Cited by 1,839
Neurotrophins as synaptic modulators
Poo, M.-M. (2001) · Nature Reviews Neuroscience · doi:10.1038/35049004 · Cited by 1,775 · cited 2×
“Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family of growth factors and is essential in modulating memory-associated neuroplasticity through regulating cell survival, proliferation, and synaptic growth in the developing central nervous system (Poo 2001; Egan et al. 2003).”
BackgroundTransport of brain-derived neurotrophic factor across the blood–brain barrier
Pan, W., Banks, W. A., Fasold, M. B., Bluth, J., & Kastin, A. J. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00141-5 · Cited by 1,354 · cited 2×
“Although the studies showed that BDNF can cross the blood–brain barrier (Pan et al.1998), and BDNF levels in serum have been positively correlated with that of the brain (Karege et al.2002), there has been no direct evidence to prove that the peripheral levels of BDNF may reflect the levels of BDNF…”
BackgroundPatterson, S. L., Abel, T., Deuel, T. A. S., Martin, K. C., Rose, J. C., & Kandel, E. R. (1996) · Neuron · doi:10.1016/s0896-6273(00)80140-3 · Cited by 1,233 · cited 2×
“1996) or by treating with recombinant BDNF (Patterson et al. 1996).”
BackgroundThe effect of exercise-induced arousal on cognitive task performance: a meta-regression analysis
Lambourne, K., & Tomporowski, P. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.091 · Cited by 1,105 · cited 1×
“Second, several studies have shown that exercise may enhance cognitive function in young, healthy, adults, and also may reduce the risk of developing dementia or ameliorate cognitive impairment already present in those suffering from neurodegenerative decline (Lambourne and Tomporowski 2010).”
BackgroundGuzowski, J. F., Lyford, G. L., Stevenson, G. D., Houston, F. P., McGaugh, J. L., Worley, P. F., & Barnes, C. A. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-03993.2000 · Cited by 992
Postnatal Developmental Profile of Brain-Derived Neurotrophic Factor in Rat Brain and Platelets
Karege, F., Schwald, M., & Cisse, M. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00529-3 · Cited by 799 · cited 2×
“…showed that BDNF can cross the blood–brain barrier (Pan et al.1998), and BDNF levels in serum have been positively correlated with that of the brain (Karege et al.2002), there has been no direct evidence to prove that the peripheral levels of BDNF may reflect the levels of BDNF in the brain and…”
Background
Research works printed but not linked: 1
- Zhang BH, Tan YL, Zhang WF, Wang ZR, Yang GG, Shi C, Zhang XY, Zhou DF (2009) Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) as a screening test in Chinese: reliability and validity. Chin Ment Health J 28:865–869
Cited by
Brain-derived neurotrophic factor and its clinical Implications
Bathina, S., & Das, U. N. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.56342 · Cited by 1,381
“In fact, it has been suggested that decreased serum BDNF levels may have a role in the pathophysiology of cognitive deficits noted in patients with type 2 diabetes mellitus [114].”
BackgroundGlucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review
Geijselaers, S. L. C., Sep, S. J. S., Stehouwer, C. D. A., & Biessels, G. J. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70148-2 · Cited by 377
Neuroprotective effect of SGLT2 inhibitors.
Pawlos, A., Broncel, M., Woźniak, E., & Gorzelak-Pabiś, P. (2021) · Molecules · doi:10.3390/molecules26237213 · Cited by 304
“Interestingly, a significant decline of BDNF was observed in patients with T2DM, and it was associated with cognitive impairment, which was not observed in non-diabetic controls [64].”
BackgroundDiagnostic, Prognostic, and Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline
Ehtewish, H., Arredouani, A., & El-Agnaf, O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116144 · Cited by 175
Hamzé, R., Delangre, E., Tolu, S., Moreau, M., Janel, N., Bailbé, D., & Movassat, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315287 · Cited by 158
“In addition, DYRK1A has been shown to be associated with hyperhomocysteinemia and reduced BDNF in AD [68,253], but also in patients with T2D [254,255].”
Background
Metadata
- Authors
- Zhen, Y. F., Zhang, J., Liu, X. Y., Fang, H., Tian, L. B., Zhou, D. H., Kosten, T. R., & Zhang, X. Y.
- Affiliations
- Hebei Medical University (CN)
- Linyi People's Hospital (CN)
- Michael E. DeBakey VA Medical Center (US)
- Corresponding author
- Fang, Hui
- Zhang, Xiang Yang
- Venue
- Psychopharmacology
- Published
- 2012-12-22
- Volume
- 227
- Issue
- 1
- Pages
- 93-100
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W1990434571
- Cited by
- 126
- References
- 43
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 11 · 2023: 23 · 2022: 13 · 2021: 10 · 2020: 9 · 2019: 9 · 2018: 6 · 2017: 9 · 2016: 8 · 2015: 9 · 2014: 5 · 2013: 5
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Stanley Medical Research Institute
- National Institutes of Health
- National Institute of Mental Health (U01MH079639, U01-MH79639)
- National Institute on Drug Abuse (K05DA0454, K05DA000454, P50-DA18827)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- brain-derived neurotrophic factor, type 2 diabetes, cognitive impairment, delayed memory, serum BDNF, RBANS, neuroplasticity, hippocampus, attention, visuospatial ability
- MeSH terms
- Adult, Aged, Cognition Disorders, Diabetes Mellitus, Type 2, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Psychomotor Performance, Biomarkers, Brain-Derived Neurotrophic Factor, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Low BDNF is associated with cognitive deficits in patients with type 2 diabetes. https://app.cochat.ai/papers/10.1007/s00213-012-2942-3
- The paper
- Zhen, Y. F., Zhang, J., Liu, X. Y., Fang, H., Tian, L. B., Zhou, D. H., Kosten, T. R., & Zhang, X. Y. (2013). Low BDNF is associated with cognitive deficits in patients with type 2 diabetes. Psychopharmacology. https://doi.org/10.1007/s00213-012-2942-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.